Clinical Trials Sponsored by National Cancer Institute, Naples

Total 22096 results

National Cancer Institute, Naples

Recruiting

Neo-adjuvant Chemo and Immunotherapy in The Pre-operAtive Treatment of Locally Advanced cholangIOcarciNoma

Cholangiocarcinoma

Italy
National Cancer Institute, Naples

Recruiting

Multidisciplinary Integrated Platform for a Technological Innvovative Approach to Oncotherapies

Biologic

Italy
National Cancer Institute, Naples

Recruiting

Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer. (Selebrec)

Breast Cancer

Italy
National Cancer Institute, Naples

Recruiting

Study on Gynecological Rare Cancers (MITO9B)

Gynecologic Cancer

Italy
National Cancer Institute, Naples

Recruiting

MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. (MITO 35B)

Ovarian Cancer

Italy
National Cancer Institute, Naples

Recruiting

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients With LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells) (PRELUDE-1)

Colorectal Cancer Metastatic

Italy
National Cancer Institute, Naples

Recruiting

Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer (REVOLUTION)

Ras-mutated Metastatic Colorectal Cancer

Italy
National Cancer Institute, Naples

Recruiting

Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study (MITO 31)

BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Italy
National Cancer Institute, Naples

Recruiting

Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer (MITO 22)

Low-grade Serous Ovarian Carcinoma | Recurrent Invasive Borderline Serous Ovarian Cancer

Italy
National Cancer Institute, Naples

Active, not recruiting

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

Neoplasm Malignant

Italy
National Cancer Institute, Naples

Active, not recruiting

Comparison of Bowel Cleansing Regimens Prior to Colonoscopy (PRECOL2011-1)

Patients Undergoing Elective Colonoscopy

Italy
National Cancer Institute, Naples

Active, not recruiting

Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval (MITO-8)

Ovarian Cancer

Italy, Belgium, Germany
National Cancer Institute, Naples

Completed

Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer (TIR-2009-01)

Thyroid Cancer

Italy
National Cancer Institute, Naples

Active, not recruiting

Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras (CALLAS)

Metastatic Colorectal Cancer

Italy
National Cancer Institute, Naples

Active, not recruiting

Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer (STREAM)

Advanced Colorectal Cancer

Italy
National Cancer Institute, Naples

Active, not recruiting

Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) (TOCIVID-19)

COVID-19 Pneumonia

Italy
National Cancer Institute, Naples

Active, not recruiting

Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated (Break-1)

Advanced Cancer

Italy
National Cancer Institute, Naples

Active, not recruiting

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy (PETRA)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB

Italy
National Cancer Institute, Naples

Active, not recruiting

MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer (MILES-4)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB

Italy
National Cancer Institute, Naples

Active, not recruiting

STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study (STAD-1)

Small Cell Lung Cancer

Italy
National Cancer Institute, Naples

Completed

Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer (MITO-11)

Ovarian Cancer

Italy
National Cancer Institute, Naples

Terminated

Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma (BOOST)

Advanced Adult Hepatocellular Carcinoma

Italy
National Cancer Institute, Naples

Completed

ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment

Breast Cancer

Italy
National Cancer Institute, Naples

Completed

MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer (MITO-5)

Ovarian Cancer

Italy
National Cancer Institute, Naples

Terminated

The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer (DISTAL-2)

Advanced Non-Small Cell Lung Cancer

Italy
National Cancer Institute, Naples

Withdrawn

ELBA: Exemestane and Lapatinib in Advanced Breast Cancer (ELBA)

Breast Cancer

Italy
National Cancer Institute, Naples

Completed

CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer (CALC-1)

Advanced Non-Small Cell Lung Cancer

Italy
National Cancer Institute, Naples

Completed

END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin

Endometrial Cancer

Italy
National Cancer Institute, Naples

Recruiting

Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas

Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of the Anus

Italy
National Cancer Institute, Naples

Recruiting

Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients. (GYNGER)

Gynecologic Cancer

Italy
National Cancer Institute, Naples

Recruiting

MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer (MITO 35a)

Ovarian Cancer

Italy
National Cancer Institute, Naples

Recruiting

Validation of the Italian Version of the PRO-CTCAE

Malignant Neoplasms

Italy
National Cancer Institute, Naples

Recruiting

Second Look Laparoscopy in Colorectal Cancer (HIPEC)

Colorectal Cancer

Italy
National Cancer Institute, Naples

Active, not recruiting

MAnagement of METastatic Disease In Campania (MAMETIC) (MAMETIC)

Metastatic Disease

Italy
National Cancer Institute, Naples

Active, not recruiting

Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer (MITO CERV 2)

Cervical Cancer

Italy
National Cancer Institute, Naples

Completed

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma (SICOG 0109)

Recurrent Melanoma | Malignant Melanoma
National Cancer Institute, Naples

Active, not recruiting

MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer (MILES-3)

Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage IIIB

Italy
National Cancer Institute, Naples

Active, not recruiting

PET/CT Scan as a Tool to Rationalize the Treatment of Patients With Advanced ColoRectal Cancer Undergoing First-line Medical Treatment (PETRA2 - CRC)

Colorectal Cancer Stage IV

Italy
National Cancer Institute, Naples

Active, not recruiting

Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer (ZIDON)

Pain | Cancer | Neuropathic Pain | Intractable Pain

Italy
National Cancer Institute, Naples

Active, not recruiting

Pathway to Diagnosis of Ovarian Cancer (MITO-12)

Ovarian Cancer

Italy, Belgium, Germany
National Cancer Institute, Naples

Completed

Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer (IMPROVE)

Colorectal Cancer Stage IV

Italy
National Cancer Institute, Naples

Completed

Temozolomide for Second-Line Treatment of Neuroendocrine Carcinomas (TENEC)

Neuroendocrine Carcinomas

Italy
National Cancer Institute, Naples

Completed

Octreotide LAR in the Induction of Immunologic Response in NENs Patients (CSMS99)

Neuroendocrine Tumors

Italy
National Cancer Institute, Naples

Unknown

REINFORCEMENT ANASTOMOSIS WITH Modified Cyanacrylate IN Patients Undergoing to Oncologic Colorectal Surgery With Colorectal Anastomosis (ANASTOSEAL)

Colorectal Cancer

Italy
National Cancer Institute, Naples

Completed

MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer

Ovarian Cancer

Italy
National Cancer Institute, Naples

Withdrawn

CETRA: Neoadjuvant Caelyx and Trastuzumab in Her-2 Positive Breast Cancer (CETRA)

Breast Cancer

Italy
National Cancer Institute, Naples

Completed

MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung Cancer

Non Small Cell Lung Cancer
National Cancer Institute, Naples

Completed

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer (ZANTE)

Metastatic Prostate Cancer

Italy
National Cancer Institute, Naples

Recruiting

The ONCOCAMP Study

Oncology

Italy
National Cancer Institute, Naples

Recruiting

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

Hepatocellular Carcinoma

Italy

3

Subscribe